This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (145)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

Alan F. Hofmann, MD

Arch Intern Med. 1999;159:2647-2658.

Bile acids, the water-soluble, amphipathic end products of cholesterol metabolism, are involved in liver, biliary, and intestinal disease. Formed in the liver, bile acids are absorbed actively from the small intestine, with each molecule undergoing multiple enterohepatic circulations before being excreted. After their synthesis from cholesterol, bile acids are conjugated with glycine or taurine, a process that makes them impermeable to cell membranes and permits high concentrations to persist in bile and intestinal content. The relation between the chemical structure and the multiple physiological functions of bile acids is reviewed. Bile acids induce biliary lipid secretion and solubilize cholesterol in bile, promoting its elimination. In the small intestine, bile acids solubilize dietary lipids promoting their absorption. Bile acids are cytotoxic when present in abnormally high concentrations. This may occur intracellularly, as occurs in the hepatocyte in cholestasis, or extracellulary, as occurs in the colon in patients with bile acid malabsorption. Disturbances in bile acid metabolism can be caused by (1) defective biosynthesis from cholesterol or defective conjugation, (2) defective membrane transport in the hepatocyte or ileal enterocyte, (3) defective transport between organs or biliary diversion, and (4) increased bacterial degradation during enterohepatic cycling. Bile acid therapy involves bile acid replacement in deficiency states or bile acid displacement by ursodeoxycholic acid, a noncytotoxic bile acid. In cholestatic liver disease, administration of ursodeoxycholic acid decreases hepatocyte injury by retained bile acids, improving liver tests, and slowing disease progression. Bile acid malabsorption may lead to high concentrations of bile acids in the colon and impaired colonic mucosal function; bile acid sequestrants provide symptomatic benefit for diarrhea. A knowledge of bile acid physiology and the perturbations of bile acid metabolism in liver and digestive disease should be useful for the internist.

From the Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(22):2751.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modulation of Bile Acid Metabolism by 1{alpha}-Hydroxyvitamin D3 Administration in Mice
Nishida et al.
Drug Metab. Dispos. 2009;37:2037-2044.
ABSTRACT | FULL TEXT  

Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C
Sarwar et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2009;297:G532-G538.
ABSTRACT | FULL TEXT  

Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP)
Lam et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2009;297:G90-G97.
ABSTRACT | FULL TEXT  

Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats
Ohta et al.
Toxicol Pathol 2009;37:521-535.
ABSTRACT | FULL TEXT  

Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
Alnouti
Toxicol Sci 2009;108:225-246.
ABSTRACT | FULL TEXT  

The cell-envelope proteome of Bifidobacterium longum in an in vitro bile environment
Ruiz et al.
Microbiology 2009;155:957-967.
ABSTRACT | FULL TEXT  

Vitamin D3 Modulates the Expression of Bile Acid Regulatory Genes and Represses Inflammation in Bile Duct-Ligated Mice
Ogura et al.
J. Pharmacol. Exp. Ther. 2009;328:564-570.
ABSTRACT | FULL TEXT  

Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis
Modica et al.
Cancer Res. 2008;68:9589-9594.
ABSTRACT | FULL TEXT  

Identification of Human Hepatic Cytochrome P450 Enzymes Involved in the Biotransformation of Cholic and Chenodeoxycholic Acid
Deo and Bandiera
Drug Metab. Dispos. 2008;36:1983-1991.
ABSTRACT | FULL TEXT  

Evolution of the bile salt nuclear receptor FXR in vertebrates
Reschly et al.
J. Lipid Res. 2008;49:1577-1587.
ABSTRACT | FULL TEXT  

Impact of Impurity on Kinetic Estimates from Transport and Inhibition Studies
Gonzalez and Polli
J. Pharmacol. Exp. Ther. 2008;326:296-305.
ABSTRACT | FULL TEXT  

Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia
Ishizawa et al.
J. Lipid Res. 2008;49:763-772.
ABSTRACT | FULL TEXT  

Biotransformation of Lithocholic Acid by Rat Hepatic Microsomes: Metabolite Analysis by Liquid Chromatography/Mass Spectrometry
Deo and Bandiera
Drug Metab. Dispos. 2008;36:442-451.
ABSTRACT | FULL TEXT  

Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts
Annaba et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2008;294:G489-G497.
ABSTRACT | FULL TEXT  

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim et al.
J. Lipid Res. 2007;48:2664-2672.
ABSTRACT | FULL TEXT  

FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption
Jung et al.
J. Lipid Res. 2007;48:2693-2700.
ABSTRACT | FULL TEXT  

Ritonavir, Saquinavir, and Efavirenz, but Not Nevirapine, Inhibit Bile Acid Transport in Human and Rat Hepatocytes
McRae et al.
J. Pharmacol. Exp. Ther. 2006;318:1068-1075.
ABSTRACT | FULL TEXT  

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids
Zollner et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2006;290:G923-G932.
ABSTRACT | FULL TEXT  

Bile salt biotransformations by human intestinal bacteria
Ridlon et al.
J. Lipid Res. 2006;47:241-259.
ABSTRACT | FULL TEXT  

Lithocholic Acid Feeding Induces Segmental Bile Duct Obstruction and Destructive Cholangitis in Mice
Fickert et al.
Am. J. Pathol. 2006;168:410-422.
ABSTRACT | FULL TEXT  

The Human Na+-Taurocholate Cotransporting Polypeptide Gene Is Activated by Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha}, and Suppressed by Bile Acids via a Small Heterodimer Partner-Dependent Mechanism
Eloranta et al.
Mol. Endocrinol. 2006;20:65-79.
ABSTRACT | FULL TEXT  

{alpha}-Crystallin Is a Target Gene of the Farnesoid X-activated Receptor in Human Livers
Lee et al.
J. Biol. Chem. 2005;280:31792-31800.
ABSTRACT | FULL TEXT  

Vitamin D Receptor-dependent Regulation of Colon Multidrug Resistance-associated Protein 3 Gene Expression by Bile Acids
McCarthy et al.
J. Biol. Chem. 2005;280:23232-23242.
ABSTRACT | FULL TEXT  

Genetics of familial intrahepatic cholestasis syndromes
van Mil et al.
J. Med. Genet. 2005;42:449-463.
ABSTRACT | FULL TEXT  

The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
Lew et al.
J. Biol. Chem. 2004;279:8856-8861.
ABSTRACT | FULL TEXT  

Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry
Hofmann
Gut 2003;52:1239-1241.
FULL TEXT  

Growth Hormone Modulation of the Rat Hepatic Bile Transporter System in Endotoxin-Induced Cholestasis
Mesotten et al.
Endocrinology 2003;144:4008-4017.
ABSTRACT | FULL TEXT  

Peroxisome Proliferator-activated Receptor {alpha} Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme
Barbier et al.
J. Biol. Chem. 2003;278:32852-32860.
ABSTRACT | FULL TEXT  

Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump
Cui et al.
J. Biol. Chem. 2003;278:10214-10220.
ABSTRACT | FULL TEXT  

Bile Acid-Induced Mallory Body Formation in Drug-Primed Mouse Liver
Fickert et al.
Am. J. Pathol. 2002;161:2019-2026.
ABSTRACT | FULL TEXT  

Ca2+- and PKC-dependent stimulation of PGE2 synthesis by deoxycholic acid in human colonic fibroblasts
Zhu et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2002;283:G503-G510.
ABSTRACT | FULL TEXT  

Lithocholic Acid Decreases Expression of Bile Salt Export Pump through Farnesoid X Receptor Antagonist Activity
Yu et al.
J. Biol. Chem. 2002;277:31441-31447.
ABSTRACT | FULL TEXT  

Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
Chiang
Endocr. Rev. 2002;23:443-463.
ABSTRACT | FULL TEXT  

The Amino Acid Residues Asparagine 354 and Isoleucine 372 of Human Farnesoid X Receptor Confer the Receptor with High Sensitivity to Chenodeoxycholate
Cui et al.
J. Biol. Chem. 2002;277:25963-25969.
ABSTRACT | FULL TEXT  

Enhanced solubilization and intestinal absorption of cholesterol by oxidized linoleic acid
Penumetcha et al.
J. Lipid Res. 2002;43:895-903.
ABSTRACT | FULL TEXT  

Nuclear Receptors: I. Nuclear receptors and bile acid homeostasis
Goodwin and Kliewer
Am. J. Physiol. Gastrointest. Liver Physiol. 2002;282:G926-G931.
ABSTRACT | FULL TEXT  

25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles
Javitt
J. Lipid Res. 2002;43:665-670.
ABSTRACT | FULL TEXT  

The Diet1 Locus Confers Protection against Hypercholesterolemia through Enhanced Bile Acid Metabolism
Phan et al.
J. Biol. Chem. 2002;277:469-477.
ABSTRACT | FULL TEXT  

Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450
Schuetz et al.
J. Biol. Chem. 2001;276:39411-39418.
ABSTRACT | FULL TEXT  

New horizons in the regulation of bile acid and lipid homeostasis: critical role of the nuclear receptor FXR as an intracellular bile acid sensor
ARRESE and KARPEN
Gut 2001;49:465-466.
FULL TEXT  

Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis
Wang et al.
Proc. Natl. Acad. Sci. USA 2001;98:2011-2016.
ABSTRACT | FULL TEXT